CIMNE-CRISPR: A novel amplification-free diagnostic for rapid early detection of African Swine Fever Virus
Biosensors and Bioelectronics · 2025-04 · 273 · 117154
DOI: 10.1016/j.bios.2025.117154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-04. Verfasst von Tathagata Pal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of California Riverside, Riverside, CA, 92521, USA. Electronic address: prameyo@gmail.com. Hauptthemen laut MEDLINE: African Swine Fever Virus, Biosensing Techniques, African Swine Fever, DNA, Viral. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, David O. McKay School of Education, Brigham Young University, NIH National Institute of General Medical Sciences.
Abstract (Originalsprache)
African Swine Fever Virus (ASFV) is a highly contagious pathogen with nearly 100% mortality in swine, causing severe global economic loss. Current detection methods rely on nucleic acid amplification, which requires specialized equipment and skilled operators, limiting accessibility in resource-constrained settings. To address these challenges, we developed the Covalently Immobilized Magnetic Nanoparticles Enhanced CRISPR (CIMNE-CRISPR) system. This amplification-free diagnostic system seamlessly combines target recognition, sequence-specific enrichment, and signal generation. This approach uses covalent immobilization of CRISPR-LbCas12a-crRNA complexes on Fe3O4@SiO2 core-shell magnetic nanoparticles, which improves enzyme specificity and robustness over traditional adsorption. The CIMNE-CRISPR assay reached a limit of detection (LOD) of 8.1 × 104 copies/μL and a limit of quantification (LOQ) of 4.2 × 105 copies/μL, with a dynamic range spanning 105 to 1010 copies/μL and a matrix factor of 100.29% in porcine plasma. It maintained great specificity and accurately detecting 105 copies/μL of ASFV DNA even with high mutant concentrations (1013 copies/μL). The method demonstrated decent reproducibility across different nanoparticle synthesis batches, with an RSD of 9.63% and recovery rates between 97% and 103%, and features rapid processing well-suited for field diagnostics. Overall, this system's cost-effectiveness, simplicity, and reliability highlight its potential to pave the way for advanced CRISPR-based diagnostics, particularly for diverse viral and bacterial targets in agricultural, environmental, and zoonotic disease contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of California Riverside, Riverside, CA, 92521, USA. Electronic address: prameyo@gmail.com.
- Department of Bioengineering, University of California Riverside, Riverside, CA, 92521, USA.
- Department of Bioengineering, University of California Riverside, Riverside, CA, 92521, USA. Electronic address: jchen@ucr.edu.
Förderung
- NIGMS NIH HHS
- David O. McKay School of Education, Brigham Young University
- NIH National Institute of General Medical Sciences
Zitieren
APA
Pal, T., Liu, Z., & Chen, J. (2025). CIMNE-CRISPR: A novel amplification-free diagnostic for rapid early detection of African Swine Fever Virus. Biosensors and Bioelectronics, 273, 117154. https://doi.org/10.1016/j.bios.2025.117154
Vancouver
Pal T, Liu Z, Chen J. CIMNE-CRISPR: A novel amplification-free diagnostic for rapid early detection of African Swine Fever Virus. Biosensors and Bioelectronics. 2025;273:117154. doi:10.1016/j.bios.2025.117154
BibTeX
@article{Pal2025,
author = {Pal, Tathagata and Liu, Zilong and Chen, Juhong},
title = {CIMNE-CRISPR: A novel amplification-free diagnostic for rapid early detection of African Swine Fever Virus},
journal = {Biosensors and Bioelectronics},
year = {2025},
volume = {273},
pages = {117154},
doi = {10.1016/j.bios.2025.117154}
}
EUVIMED